TERMINATED

Auricular Neurostimulation for Chemotherapy Induced Nausea and Vomiting

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study evaluates the efficacy of auricular percutaneous electrical nerve field stimulator in children, adolescents and young adults with chemotherapy induced nausea and vomiting.

Official Title

Efficacy of Auricular Neurostimulation for Children Adolescents and Young Adults With Chemotherapy Induced Nausea and Vomiting

Quick Facts

Study Start:2021-04-29
Study Completion:2025-09-23
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:TERMINATED

Study ID

NCT05143554

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:4 Years to 30 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Subjects who are scheduled to be admitted for chemotherapy administration and who will have at least one additional cycle of the same chemotherapy
  2. * Chemotherapy regimens must include moderate and/or severe emetogenic chemotherapy
  1. * Significant developmental delays that would prohibit participation
  2. * Infection or severe dermatological condition of ear
  3. * Uncontrolled or severe infection
  4. * No implanted electrical device is permitted
  5. * Pregnancy
  6. * Severe cardiopulmonary disease
  7. * Diagnosis of hemophilia or other bleeding disorders
  8. * Diagnosis psoriasis vulgaris

Contacts and Locations

Study Locations (Sites)

Children's Wisconsin Hospital
Milwaukee, Wisconsin, 53226
United States

Collaborators and Investigators

Sponsor: Medical College of Wisconsin

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-04-29
Study Completion Date2025-09-23

Study Record Updates

Study Start Date2021-04-29
Study Completion Date2025-09-23

Terms related to this study

Additional Relevant MeSH Terms

  • Chemotherapy-induced Nausea and Vomiting